Take Solutions has received approval for the disinvestment of 100% equity stake of TAKE Solutions in Ecron Acunova, a wholly owned subsidiary, subject to completion of necessary due diligence formalities and obtaining approval of the shareholders. The said sale/disposal is expected to be completed on or before October 30, 2024, subject to necessary approvals. Consideration received from such sale/disposal is $6.50 million. The Board of Directors of the Company, in its meeting held on September 13, 2024, after taking into consideration the recommendation of the committee of Independent Directors, have considered and approved the same.
Take Solutions delivers domain-intensive services in Life Sciences and Supply Chain Management. The company offers clients a unique combination of full service Clinical, Regulatory and Safety services with unique technology expertise. The company's services span clinical trials to regulatory submissions to post-marketing strategy with insights derived through proprietary industry network forums.
